相关实验视频

Updated: Jun 26, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌:系统疗法的进展

Trevor Kwan-Hung Wu¹, Rex Wan-Hin Hui¹, Lung-Yi Mak^1,2

¹Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, Hong Kong.

|May 20, 2024

概括

系统疗法,包括向药物和免疫疗法,已经改变了晚期肝细胞癌 (HCC) 治疗. 新的组合显示出希望,扩大了HCC患者的传统化疗之外的选择.

科学领域:

肝病学肝病学是一种肝病学.
医学瘤学医学瘤学
翻译研究是翻译研究.

背景情况:

晚期肝细胞癌 (HCC) 在历史上具有有限的治疗选择和糟糕的结果.
索拉菲尼布是一种氨酸激酶抑制剂,是2007年批准用于高级HCC的第一个全身性药物.
最近的进展包括向疗法和免疫疗法,显著提高了生存率.

研究的目的:

审查先进的HCC系统疗法的不断变化的格局.
突出新的组合策略及其有效性.
讨论系统治疗的扩大指示和未来的研究方向.

主要方法:

审查最近的临床试验和指导方针更新.
对组合疗法的分析,包括阿特佐利祖马布加贝瓦齐祖马布和杜尔瓦卢马布加特雷梅利穆马布.
在新辅助,辅助和下降阶段设置中探索全身疗法.

主要成果:

向疗法和免疫疗法已经彻底改变了先进的HCC治疗.
联合治疗方案,如阿特佐利祖马布/贝瓦西祖马布和杜尔瓦卢马布/特雷梅利穆马布,显示出令人鼓舞的疗效.
系统性药物越来越多地与局部区域疗法并用于新辅助/辅助治疗一起使用.

结论:

晚期HCC的治疗模式已经转向新的全身性药物和组合.
需要进一步的研究,以了解特定患者亚组的现实疗效以及肝病病因学的影响.
个性化治疗决策将由对病理生理学和临床数据积累的更好理解所驱动.

关键词:

辅助剂辅助剂是一种辅助剂.在HCC中,HCC是HCC.ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI IC1 ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI ICI IC1 ICI IC1 IC1 IC1 IC2 IC2 IC1 IC1 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 IC2 which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which which 肝脏肝脏肝脏肝脏新辅助剂是一种新辅助剂.系统性疗法是一种全身疗法.这里是TKI TKI.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.